Acasti Pharma Operating Income 2014-2023 | ACST

Acasti Pharma operating income from 2014 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Acasti Pharma Annual Operating Income
(Millions of US $)
2023 $-52
2022 $-16
2021 $-16
2020 $-24
2019 $-34
2018 $-15
2017 $-8
2016 $-7
2015 $-8
2015 $
2014 $-10
2014 $
2013 $-7
2013 $
Acasti Pharma Quarterly Operating Income
(Millions of US $)
2023-12-31 $-3
2023-09-30 $-2
2023-06-30 $-4
2023-03-31 $-38
2022-12-31 $-4
2022-09-30 $-5
2022-06-30 $-5
2022-03-31 $-4
2021-12-31 $-4
2021-09-30 $-4
2021-06-30 $-3
2021-03-31 $-2
2020-12-31 $-2
2020-09-30 $-8
2020-06-30 $-4
2020-03-31 $-4
2019-12-31 $-6
2019-09-30 $-6
2019-06-30 $-8
2019-03-31 $-11
2018-12-31 $-8
2018-09-30 $-8
2018-06-30 $-8
2018-03-31 $-6
2017-12-31 $-4
2017-09-30 $-3
2017-06-30 $-2
2017-02-28 $-2
2016-11-30 $-2
2016-08-31 $-2
2016-05-31 $-2
2016-03-31 $-0
2016-02-29
2015-12-31 $-2
2015-09-30 $-2
2015-06-30 $-2
2015-03-31 $0
2014-12-31 $-3
2014-09-30 $-3
2014-06-30 $-3
2014-03-31 $0
2014-02-28
2013-12-31 $-3
2013-09-30 $-3
2013-06-30 $-2
2013-03-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.028B $0.000B
Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.855B 5.36
Dr Reddy's Laboratories (RDY) India $12.352B 19.53
Aspen Pharmacare (APNHY) South Africa $5.038B 0.00
BridgeBio Pharma (BBIO) United States $4.278B 0.00
Bausch Health Cos (BHC) Canada $3.150B 2.46
Amphastar Pharmaceuticals (AMPH) United States $1.995B 13.66
Supernus Pharmaceuticals (SUPN) United States $1.604B 0.00
Taysha Gene Therapies (TSHA) United States $0.430B 0.00
Generation Bio (GBIO) United States $0.200B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Personalis (PSNL) United States $0.063B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00